Abstract
269 adult patients were included into the trial by the overall irrevocable sample method. 58%
patients were female. The frequency of atrial fibrillation (AF) was 14,9% (in females it is significantly
more frequent - 18,6%, in males - 9,7%). Clinical and social differences with and without
AF were detected between patients; part of them was possibly established by interconnected
with AF factor (the patient`s age) that is necessary to include in selecting of tactics for patients`
management. In general, medical treatment of patients is appropriate to recommendations of
ARSSC and worldwide practice as surgical methods of cardiovascular diseases (including AF)
are used rarely and don`t correspond to revealed necessities.
References
1. Алекян, Б. Г. Рентгеноэндоваскулярная хирургия хронических тотальных окклюзий коронарных артерий / Б. Г. Алекян, А. В. Стаферов // Руководство по рентгеноэндовакулярной хирургии заболеваний сердца и сосудов / Под ред. Л. А. Бокерия, Б. Г. Алекяна. - М., 2008. - Т. 3. - С. 527-558.
2. Бокерия, Л. А. Применение стентов с антипролиферативным покрытием в лечении больных ишемической болезнью сердца / Л. А. Бокерия, Б. Г. Алекян, Е. З. Голухова и др. // Креат. кардиол. - 2007. - № 1-2.- С. 183-199.
3. Ганюков, В. И. Объем жизнеспособного миокарда и коллатеральный кровоток у пациентов с окклюзией коронарных сосудов / В. И. Ганюков // Грудная и серд.-сосуд. хир.-2004.-№1.- С. 30-33.
4. Осиев, А. Г. Факторы риска и предикторы успеха чрескожных коронарных вмешательств у больных с хроническими окклюзиями коронарных артерий / А. Г. Осиев, С. П. Мироненко, Л. Е. Слайковская и др. // Патол. кровообр. и кардиохир. - 2004. - № 4. - С. 4-8.
5. Anderson, H. V. A contemporary overview of percutaneous coronary interventions. The ACC-NCDR / H. V. Anderson, R. E. Shaw, R. G. Brindis et al. // J. Amer. Coll. Cardiol. - 2002. - Vol. 39. - P. 1096-1103.
6. Aziz, S. Percutaneous coronary intervention for chronic total occlusions: improved survival for patients with successful revascularization compared to a failed procedure / S. Aziz, R. H. Stables, A. D. Grayson et al. // Cathet. Cardiovasc. Interv. - 2007. - Vol. 70, № 1. - P. 15-20.
7. Baks, T. Prediction of left ventricular function after drug-eluting stent implantation for chronic total coronary occlusions. / T. Baks, R. J. van Geuns, D. J. Duncker et al. // J. Amer. Coll. Cardiol. - 2006. - Vol. 47, № 4. - P. 721-725.
8. Berger, P. B. Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial with Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) / P. B. Berger, D. R. Holmes Jr, E. M. Ohman et al. // J. Amer. Coll. Cardiol. - 1996. - Vol. 27. - P. 1-7.
9. Buller, S. E. Primary stenting versus balloon angioplasty in occluded coronary arteries: The Total Occlusion Study of Canada (TOSCA) / S. E. Buller, V. Dzavik, R. G. Carere et al. // Circulation. - 1999. - Vol. 100. - P. 236.
10. Di Mario, C. European perspective in recanalisation of chronic total occlusions (CTO): consensus document from the EuroCTO Club / C. Di Mario, G. S. Werner, G. Sianos et al. // Eurointerv. - 2007. - Vol. 3. - P. 30-43.
11. Ge, L. Immediate and mid-term outcomes of sirolimus eluting stent implantation for chronic total occlusions / L. Ge, I. Iakovou, J. Cosgrave et al. // Eur. Heart J. - 2005. - Vol. 26. - P. 1056-1062.
12. Haerer, W. Angioplasty of chronic total coronary occlusions. Results of a controlled randomized trial / W. Haerer, A. Schmidt, T. Eggeling et al. // J. Amer. Coll. Cardiol. - 1991. - Vol. 17. - P. 113A.
13. Han, Y. L. Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions / Y. L. Han, J. Zhang, Y. Li et al.// Chin. Med. J. (Engl.). - 2009. - Vol. 122, № 6. - P. 643-647.
14. Hodgson, J. M. Late stent thrombosis: considerations and practical advise for the use of drug-eluting stents: a report from the SCAI DES Task Forse / J. M. Hodgson, G. W. Stone, M. A. Lincoff et al. // Cath. Cardiovasc. Interv. - 2007. - Vol. 69. - P. 327-333.
15. Hoher, M. A randomized trial of elective stenting after balloon recanalization of chronic total occlusions / M. Hoher, J. Wohrle, O. C. Grebe et al. // J. Amer. Coll. Cardiol. - 1999. - Vol. 34. - P. 772.
16. Hoye, A. Drug-eluting stent implantation for chronic total occlusions: comparison between Sirolimus- and Paclitaxеl-eluting stent / A. Hoye, A. T. Ong, J. Aoki et al. // Eurointerv. - 2005. - Vol. 1. - P. 193-197.
17. Hoye, A. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions / A. Hoye, K. Tanabe, P. A. Lemos et al. // J. Amer. Coll. Cardiol. - 2004. - Vol. 43. - P. 1954-1958.
18. Iakovou, I. Incidence, predictors, and outcome of thrombosis after successful implantation of drugeluting stents / I. Iakovou, T. Schmidt, E. Bonizzoni et al. // JAMA.- 2005. - Vol. 293. - P. 2126-2130.
19. Ishizaka, N. Angiographic follow-up after successful percutaneous coronary angioplasty for chronic total coronary occlusion: Experience in 110 consecutive patients / N. Ishizaka, T. Issiki, P. Saeki et al. // Amer. Heart. J. - 1994. - Vol. 127. - P. 8.
20. Ivanhoe, R. J. Percutaneous transluminal coronary angioplasty of chronic total occlusions: Primary success, restenosis, and long-term clinical follow-up / R. J. Ivanhoe, W. S. Weintraub, J. S. Jr. Douglas et al. // Circulation. - 1992. - Vol. 85. - P. 106-115.
21. Jang, J. S. Comparison between sirolimus- and Paclitaxel- eluting stents for the treatment of chronic total occlusions / J. S. Jang, M. K. Hong, C. W. Lee et al. // J. Invasive Cardiol. - 2006. - Vol. 18, № 5. - P. 209-210.
22. Kandzari, D. E. ACROSS/TOSCA-4 Investigators. Clinical and angiographic outcomes with sirolimuseluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents / Total Occlusion Study of Coronary Arteries-4) trial / D. E. Kandzari, S. V. Rao, J. W. Moses et al. // JACC Cardiovasc. Interv. - 2009. - Vol. 2, № 2. - P. 97-106.
23. Kastrati, A. Analysis of 14 trials comparing sirolimus eluting stents with bare-metal stents. / A. Kastrati, J. Mehilli, J. Pache et al. // N. Engl. J. Med. - 2007. - Vol. 356. - P. 1030-1039.
24. Kelbaek, H. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial / H. Kelbaek, S. Helqvist, L. Thuesen et al. // Amer. Heart J. - 2006. - Vol. 152, №5. - P. 882-886.
25. King, S. B. III. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention / S. B. King III, S. C. Smith, J. W. Hirshfeld Jr et al. // Cathet. Cardiovasc. Interv. - 2007. - Vol. 71. - P. E1-E40.
26. Kobayashi, Y. Stented segment length as an independent predictor of restenosis / Y. Kobayashi, J. De Gregorio, N. Kobayashi et al. // J. Amer. Coll. Cardiol. - 1999. - Vol. 34. - P. 651-659.
27. Leon, M. B. An Evidence-Based Medicine Appraisal of Clinical Indications for Drug-Eluting Stents - Appropriate Use, Abuse, and Uncertainties / M. B. Leon // Presentation on TCT, Washington, October 2006 (Downloaded from: http://www.tctmd.com).
28. Lotan, C. Sirolimus-eluting stent in chronic total occlusion: the SICTO study / C. Lotan, Y. Almagor, K. Kuiper et al. // J. Interv. Cardiol. - 2006. - Vol. 19, № 4. - P. 307-312.
29. Lotan, C. Treatment of chronic total occlusion with the sirolimus-eluting stents: 12 month results from the e-Cypher Registry / C. Lotan, A. H. Gershlick, G. Guagliumi et al. // Presented at ACC Scientific Sesion. - Orlando, 2005.
30. Lotan, C. Stents in total occlusion for restenosis prevention / C. Lotan, Y. Rozenman, A. Hendler et al. // Eur. Heart J. - 2000. - Vol. 21. - P. 1960.
31. Mauri, L. Stent thrombosis in randomized clinical trials of drug-eluting stents / L. Mauri, W. Hsieh, J. M. Massaro et al. // N. Engl. J. Med. - 2007. - Vol. 356. - P. 1020-1029.
32. Mutlak, D. M. Determinants of regional myocardial function in patients with chronic significant coronary stenosis or occlusion / D. M. Mutlak, S. Habib, W. Markiewicz, R. Beyar // Amer. Heart J. - 1998. - Vol. 136, № 1. - P. 169-175.
33. Olivari, Z. TOAST-GISE investigators. Immediate results and one year clinical outcome after percutaneous coronary interventions in chronic total occlusions: Data from a multicenter prospective observational study (TOAST-GISE) / Z. Olivari, P. Rubarrelli, F. Piscione et al. // J. Amer. Coll. Cardiol. - 2003. - Vol. 41. - P. 1672.
34. Prasad, A. Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic / A. Prasad, C. S. Rihal, R. J. Lennon et al. // J. Amer. Coll. Cardiol. - 2007. - Vol. 49, № 15. - P. 1611-1618.
35. Rahel, M. B. Primary stenting of occluded native coronary arteries: final results of Primary Stenting of Occluded Native Coronary Arteries (PRISON) study / M. B. Rahel, M. J. Suttorp, G. J. Laarmаn et al. // Amer. Heart J. - 2004. - Vol. 147. - P. e22.
36. Rahel, B. M. Three-year clinical outcome after primary senting of totally occluded native coronary arteries: A randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (Primary Stenting of Totally Occluded Native Coronary Arteries [PRISON] II study) / B. M. Rahel, G. J. Laarman, J. C. Kelder et al. // Amer. Heart J. - 2009. - Vol. 157, № 1. - P. 149-155.
37. Safley, D. M. Success rates of percutaneous coronary intervention of chronic total occlusions and longterm survival in patients with diabetes mellitus / D. M. Safley, J. A. House, B. D. Rutherford et al. // Diab. Vasc. Dis. Res. - 2006. - Vol. 3, № 1. - P. 45-51.
38. Sievert, H. Stent or angioplasty after recanalisation of chronic coronary occlusions? / H. Sievert, S. Rohde, A. Utech et al. // Amer. J. Cardiol. - 1999. - Vol. 84. - P. 386.
39. Sirnes, P. A. Stenting In Chronic Coronary Occlusions (SICCO): a randomized controlled trial of adding stent implantation after successful angioplasty / P. A. Sirnes, S. Golf, Y. Myreng et al. // J. Amer. Coll. Cardiol. - 1996. - Vol. 28. - P. 1444.
40. Smith, S. C. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention / S. C. Smith, T. E. Feldman, J. W. Hirsgfeld et al. // JACC. - 2006. - Vol. 47. - P. 1-121.
41. Stone, G. W. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: Part I / G. W. Stone, D. E. Kandzari, R. Mehran et al. // Circulation. - 2005. -Vol. 112. - Vol. P. 2364-2372.
42. Stone, G. W. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents / G. W. Stone, J. W. Moses, S. G. Ellis et al. // N. Engl. J. Med. - 2007. - Vol. 356. - P. 998-1008.
43. Stone, G. W. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: Part II / G. W. Stone, N. R. Reifart, I. Moussa et al. // Circulation. - 2005. - Vol. 112. - P. 2530-2537.
44. Stone, G. W. Procedural outcome of angioplasty for total coronary artery occlusion: an analysis of 971 lesions in 905 patients / G. W. Stone, B. D. Rutherford, D. R. McConahay et al. // J. Amer. Coll. Cardiol. - 1990. - Vol. 15. - P. 849.
45. Suero, J. A. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary interventions of a chronic total occlusions in native coronary arteries: a 20-year experience / J. A. Suero, S. P. Marso, P. G. Jones et al. // J. Amer. Coll. Cardiol. - 2001. - Vol. 38. - P. 409.
46. Suttorp, M. J. Primary stenting of totally occluded native coronary arteries II (PRISON II) / M. J. Suttorp, G. J. Laarman, B. M. Rahel et al. // Circulation. - 2006. - Vol. 114. - P. 921-928.
47. Suttorp, M. J. PRISON III study investigators. A randomized comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions: rationale and design of the PRImary Stenting of Occluded Native coronary arteries III (PRISON III) study / M. J. Suttorp, G. J. Laarman // Amer. Heart J. - 2007. - Vol. 154, № 3. - P. 432-435.
48. Werner, G. S. Prevention of lesion recurrence in chronic total occlusions by paclitaxel-eluting stents / G. S. Werner, A. Krack, G. Schwarz et al. // J. Amer. Coll. Cardiol. - 2004. - Vol. 44. - P. 2301-2306.